SE7409100L - Urinemnestabletter. - Google Patents

Urinemnestabletter.

Info

Publication number
SE7409100L
SE7409100L SE7409100A SE7409100A SE7409100L SE 7409100 L SE7409100 L SE 7409100L SE 7409100 A SE7409100 A SE 7409100A SE 7409100 A SE7409100 A SE 7409100A SE 7409100 L SE7409100 L SE 7409100L
Authority
SE
Sweden
Prior art keywords
urine substances
urine
substances
Prior art date
Application number
SE7409100A
Other languages
English (en)
Other versions
SE392037B (sv
Inventor
D C Scharland
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7409100L publication Critical patent/SE7409100L/sv
Publication of SE392037B publication Critical patent/SE392037B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7409100A 1973-07-12 1974-07-10 Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum SE392037B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3321473A GB1466857A (en) 1973-07-12 1973-07-12 Urea tablets

Publications (2)

Publication Number Publication Date
SE7409100L true SE7409100L (sv) 1975-01-13
SE392037B SE392037B (sv) 1977-03-14

Family

ID=10350041

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409100A SE392037B (sv) 1973-07-12 1974-07-10 Forfarande for framstellning av tabletter innehallande beta-laktamanti-biotikum

Country Status (12)

Country Link
US (1) US3996365A (sv)
JP (1) JPS5714650B2 (sv)
BE (1) BE817515A (sv)
CA (1) CA1039653A (sv)
DE (1) DE2433424A1 (sv)
DK (1) DK146843C (sv)
FR (1) FR2236485B1 (sv)
GB (1) GB1466857A (sv)
IE (1) IE39557B1 (sv)
NL (1) NL178563C (sv)
SE (1) SE392037B (sv)
ZA (1) ZA744243B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002924A1 (de) 2007-01-19 2008-07-24 Bayer Healthcare Ag ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679801A (en) * 1970-05-19 1972-07-25 Pfizer Aryl esters of {60 -carboxyarylmethyl-penicillins

Also Published As

Publication number Publication date
FR2236485B1 (sv) 1978-07-21
CA1039653A (en) 1978-10-03
GB1466857A (en) 1977-03-09
US3996365A (en) 1976-12-07
DK146843B (da) 1984-01-23
NL178563C (nl) 1986-04-16
AU7113574A (en) 1976-01-15
JPS5031025A (sv) 1975-03-27
DK146843C (da) 1984-07-16
IE39557B1 (en) 1978-11-08
NL7408986A (nl) 1975-01-14
ZA744243B (en) 1975-06-25
JPS5714650B2 (sv) 1982-03-25
FR2236485A1 (sv) 1975-02-07
DK374674A (sv) 1975-03-03
DE2433424A1 (de) 1975-01-30
NL178563B (nl) 1985-11-18
BE817515A (fr) 1975-01-10
SE392037B (sv) 1977-03-14
IE39557L (en) 1975-01-12

Similar Documents

Publication Publication Date Title
NL178388C (nl) Luier.
DK133480B (da) Underloft.
NL7414958A (nl) Toilet.
NL7414531A (nl) Latrine.
NL7415723A (nl) Luier.
DK138910B (da) Termovindue.
NL162017C (nl) Spoorwegwiel.
NL7406672A (nl) Al-winning.
ES189944Y (es) Sortija-brazalete.
SE7409100L (sv) Urinemnestabletter.
NO136737C (no) Formuldningstoalett.
DK141049B (da) Rodenticidt aktive 3-pyridylmethylarylurinstoffer.
NL7414069A (nl) Cumarino-3.4-oxazolen.
NO140660C (no) Dumpefartoey.
ES200953Y (es) Orinal.
FI47800C (sv) Avloppsbrunn.
ES195193Y (es) Falca.
ES187797Y (es) Muneca concertista.
ES191801Y (es) Cepillo-percha.
ES191799Y (es) Anillo-filtro.
ES191443Y (es) Aposito-braguero.
ES191253Y (es) Paralelografo.
ES190899Y (es) Remache-ojete.
ES196655Y (es) Porta-vasos.
ES192241Y (es) Muneco saltarin.